Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A, Cleeren M, Wostenborghs R, De Beule K. Boogaerts MA, et al. Among authors: de beule k. Antimicrob Agents Chemother. 2001 Mar;45(3):981-5. doi: 10.1128/AAC.45.3.981-985.2001. Antimicrob Agents Chemother. 2001. PMID: 11181397 Free PMC article. Clinical Trial.
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL, Dekker AW, Stamatoullas-Bastard A, Fassas A, Linkesch W, Gouveia J, De Bock R, Rovira M, Seifert WF, Joosen H, Peeters M, De Beule K. Harousseau JL, et al. Among authors: de beule k, de bock r. Antimicrob Agents Chemother. 2000 Jul;44(7):1887-93. doi: 10.1128/AAC.44.7.1887-1893.2000. Antimicrob Agents Chemother. 2000. PMID: 10858349 Free PMC article. Clinical Trial.
Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
Vandewoude K, Vogelaers D, Decruyenaere J, Jaqmin P, De Beule K, Van Peer A, Woestenborghs R, Groen K, Colardyn F. Vandewoude K, et al. Among authors: de beule k. Antimicrob Agents Chemother. 1997 Dec;41(12):2714-8. doi: 10.1128/AAC.41.12.2714. Antimicrob Agents Chemother. 1997. PMID: 9420044 Free PMC article. Clinical Trial.
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K; Itraconazole Neutropenia Study Group. Boogaerts M, et al. Among authors: de beule k. Ann Intern Med. 2001 Sep 18;135(6):412-22. doi: 10.7326/0003-4819-135-6-200109180-00010. Ann Intern Med. 2001. PMID: 11560454 Clinical Trial.
Itraconazole pharmacokinetics in patients with renal dysfunction.
Boelaert J, Schurgers M, Matthys E, Daneels R, van Peer A, De Beule K, Woestenborghs R, Heykants J. Boelaert J, et al. Among authors: de beule k. Antimicrob Agents Chemother. 1988 Oct;32(10):1595-7. doi: 10.1128/AAC.32.10.1595. Antimicrob Agents Chemother. 1988. PMID: 2847635 Free PMC article.
27 results